Ligand Pharmaceuticals Inc. (LGND) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for LGND. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 3,100,996 | $980M | INCREASED |
| Vanguard | 2,186,410 | $691M | INCREASED |
| Invesco Ltd | 1,201,644 | $380M | INCREASED |
| Jupiter Topco | 1,040,578 | $329M | NEW |
| State Street | 826,539 | $261M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Martine Zimmermann (Director) | SELL | 1,200 | $342K | 2026-09-10 |
| Andrew Reardon (CLO & Secretary) | SELL | 400 | $116K | 2026-09-03 |
| Andrew Reardon (CLO & Secretary) | SELL | 385 | $111K | 2026-09-03 |
| Andrew Reardon (CLO & Secretary) | SELL | 2,115 | $606K | 2026-09-03 |
| Andrew Reardon (CLO & Secretary) | SELL | 1,800 | $513K | 2026-09-03 |
Full institutional holdings, insider history, and congressional trades for Ligand Pharmaceuticals Inc. on SentiSense.